[PLX] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- 293.82%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 34,240 19,242 9,199 4,364 15,160 11,513 34,424 -0.08%
PBT -26,457 -85,276 -29,176 -27,282 -29,943 -27,790 -11,618 14.69%
Tax 536 7,805 10,854 -87,566 -2,944 0 0 -
NP -26,457 -85,276 -29,365 58,037 -29,943 -27,790 -11,618 14.69%
Tax Rate - - - - - - - -
Total Cost 60,697 104,518 38,564 -53,673 45,103 39,303 46,042 4.71%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -77.27 -443.18 -319.22 1,329.90 -197.51 -241.38 -33.75 14.79%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -1.80 -6.51 -0.29 0.61 -0.32 -0.30 -0.13 54.92%
EPS Diluted -1.80 -6.51 -0.29 0.61 -0.32 -0.30 -0.13 54.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.